𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeted therapies: Goldie–Coldman and bevacizumab beyond disease progression

✍ Scribed by Giantonio, Bruce J.

Book ID
109949160
Publisher
Nature Publishing Group
Year
2009
Tongue
English
Weight
87 KB
Volume
6
Category
Article
ISSN
1759-4774

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Telomeres and telomerase in chronic myel
Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy
✍ Gunhild Keller; Ute Brassat; Melanie Braig; Denise Heim; Henning Wege; Tim H. Br 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

## Abstract Telomeres are specialized structures localized at the end of human chromosomes. Due to the end replication problem, each cell division results in a loss of telomeric repeats in normal somatic cells. In germ line and stem cells, the multicomponent enzyme telomerase maintains the length o

Randomized Phase IIIb Trial Evaluating t
Randomized Phase IIIb Trial Evaluating the Continuation of Bevacizumab Beyond Disease Progression in Patients with Advanced Non-Squamous Non–Small-Cell Lung Cancer after First-Line Treatment with Bevacizumab Plus Platinum-Based Chemotherapy: Treatment Rationale and Protocol Dynamics of the AvaALL (MO22097) Trial
✍ Cesare Gridelli; Jaafar Bennouna; Javier de Castro; Anne-Marie C. Dingemans; Fra 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 268 KB